BC Platforms Selected as Partner to Deliver key Singapore Population Health Study
Retrieved on:
Monday, January 9, 2023
Disease, News, Ageing, Real world data, Phenotype, BCP, TRE, Nanyang Technological University, Precision medicine, RWD, Health, Genotype, Environment, Conditional sentence, Lee Kong Chian School of Medicine, Genomics, Partnership, Woman, Population health, Patient, Diabetes, Research, TCE, Cancer, Medicine, Degenerative disease, NTU, Pharmaceutical industry, Medical device
The HELIOS study is a state-of-the-art population cohort study established and led by the Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapore (NTU Singapore).
Key Points:
- The HELIOS study is a state-of-the-art population cohort study established and led by the Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapore (NTU Singapore).
- The population study aims to identify environmental, lifestyle and genetic factors that cause heart disease, diabetes, cancer, and other chronic diseases in Singapore.
- As part of Singapore’s SG100K study, the HELIOS study will recruit up to 50,000 men and women, aged 30-84 years old, from the Singapore population progressively over the next two years.
- Bringing access to the HELIOS-SG100K data through BC platforms will enable and accelerate researchers to pursue key questions around precision health and personalised medicine.